Search Within

John Conrad Messinger

Formats
  1. Meeting Abstract (5)
  2. Journal Article (1)
  3. Review (1)
Groups
  1. Surgery (6)
  2. Sloan Kettering Institute Postdocs (4)
  3. Biostatistics Service (3)
  4. Department of Medicine (3)
  5. Epidemiology and Biostatistics (3)
  6. Solid Tumor Oncology Division (3)

More Groups

People
  1. Navin Chintala (6)
  2. Prasad Adusumilli (6)
  3. Kay See Tan (3)
  4. Marjorie Zauderer (3)
  5. Stefan Kiesgen (3)
  6. Zachary Tano (3)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2019 (3)
  4. 2018 (2)
Publications
  1. Journal of Thoracic Oncology (2)
  2. Cancer Research (1)
  3. Cell Reports Methods (1)
  4. Journal of Clinical Oncology (1)
  5. Molecular Therapy (1)
  6. Nature Protocols (1)
Publishers
  1. Elsevier Inc. (2)
  2. Nature Publishing Group (2)
  3. American Association for Cancer Research (1)
  4. American Society of Clinical Oncology (1)
  5. Cell Press (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ex vivo pleural effusion cultures to study chimeric antigen receptor T cell cytotoxicity in an immunocompetent environment
    Journal Article

    Tano, Z. E.; Kiesgen, S.; Chintala, N. K.; Dozier, J.; Quach, H. T.; Messinger, J.; Tan, K. S.; Adusumilli, P. S.
    Cell Reports Methods (2023)

    Fulltext@MSK | Save
  • Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity
    Review

    Kiesgen, S.; Messinger, J. C.; Chintala, N. K.; Tano, Z.; Adusumilli, P. S.
    Nature Protocols (2021)

    Fulltext@MSK | Save
  • Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R.; Zhu, A.; Ngai, D.; McGee, E.; Chintala, N.; Messinger, J.; Cheema, W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Ngai, D. A.; McGee, E.; Chintala, N. K.; Messinger, J. C.; Vincent, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • An ex-vivo patient derived immunotherapy platform to investigate CAR T-cell efficacy against lung cancer
    Meeting Abstract

    Messinger, J.
    Molecular Therapy (2019)

    Fulltext@MSK | Save
  • An ex-vivo patient-derived, immunocompetent (PDI) culture system to evaluate immunotherapeutic agents' anti-tumor efficacy
    Meeting Abstract

    Tano, Z.; Kiesgen, S.; Chintala, N.; Dozier, J.; Messinger, J.; Tan, K. S.; Adusumilli, P.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • gC1qR expression is independently prognostic for survival benefit following chemotherapy in mesothelioma
    Meeting Abstract

    Li, X.; Eguchi, T.; Aly, R.; Chintala, N.; Tan, K. S.; Messinger, J.; Zauderer, M.; Ghebrehiwet, B.; Adusumilli, P.; Peerschke, E.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save